Company: RGBP
Filing Date: 2025-08-11
Form Type: 10-Q
Source: 0001641172-25-022884
Chunk: 13

Company: Regen BioPharma Inc
Filing Date: 2025-08-11
Form: 10-Q
Item: Part I, Item 1
Chunk 13
---
 in its discretion, from funds legally available therefore

On
any voluntary or involuntary liquidation, dissolution or winding up of Regen, the holders of the Series NC Preferred Stock shall receive,
out of assets legally available for distribution to Regen’s stockholders, a ratable share in the assets of Regen.

On
May 20, 2024 Regen Biopharma, Inc. amended its Certificate of Incorporation adding the following Article 8 which is and reads as follows:

Shares
of one class or series of stock may be issued as a share dividend in respect of another class or series.

On
May 21, 2024 the Board of Directors of Regen Biopharma, Inc declared a dividend to all shareholders of record as of June 20,2024 (“ Record
Date”) to be paid to shareholders on or about July 1, 2024 such dividend to be payable in shares of the Regen’s authorized
but unissued Series A Preferred Stock and to consist of two share of Series A Preferred Stock for every one share of Regen Biopharma,
Inc. Common Stock owned as of the Record Date, every one share of Regen Biopharma, Inc. Series A Preferred Stock owned as of the Record
Date, every one share of Series AA Preferred Stock owned as of the Record Date, every one share of Series M Preferred Stock owned as
of the Record Date and every one share of Series NC Preferred Stock owned as of the Record Date.

On
July 3, 2024 9,694,152

On
September 18, 2024 the Board of Directors of Regen Biopharma, Inc.(“ Regen”) declared a dividend to all shareholders of record
as of October 17,2024 (“ Record Date”) be paid to shareholders on November 1, 2024 such dividend to be payable in shares of
the Regen’s authorized but unissued Common Stock and to consist of one share of Common Stock for every one share of Regen Biopharma,
Inc. Common Stock owned as of the Record Date, every one share of Regen Biopharma, Inc. Series A Preferred Stock owned as of the Record
Date, every one share of Series AA Preferred Stock owned as of the Record Date, every one share of Series M Preferred Stock owned as
of the Record Date and every one share of Series NC Preferred Stock owned as of the Record Date.

On
November 1, 2024 15,426